{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T03:24:40Z","timestamp":1700537080400},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.humpath.2006.11.008","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T11:02:37Z","timestamp":1170673357000},"page":"1587.e1-1587.e6","source":"Crossref","is-referenced-by-count":8,"title":["Recommendations for the reporting of pleural mesothelioma"],"prefix":"10.1016","volume":"38","author":[{"given":"Kelly J.","family":"Butnor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Sporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson G.","family":"Ordonez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2006.11.008_bib1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2006.11.008_bib2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0003-4975(99)01038-3","article-title":"Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically","volume":"68","author":"Rusch","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2006.11.008_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000658-199609000-00005","article-title":"Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients","volume":"224","author":"Sugarbaker","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2006.11.008_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.humpath.2006.11.008_bib5","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus, and heart","first-page":"128","article-title":"Mesothelioma","author":"Churg","year":"2004"},{"key":"10.1016\/j.humpath.2006.11.008_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2006.11.008_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/modpathol.3880018","article-title":"Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5\/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura","volume":"13","author":"Cury","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2006.11.008_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3835(97)00466-7","article-title":"TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung","volume":"124","author":"Di Loreto","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2006.11.008_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/00000478-199810000-00006","article-title":"Value of cytokeratin 5\/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma","volume":"22","author":"Ordonez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2006.11.008_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ajcp\/109.1.85","article-title":"Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature","volume":"109","author":"Ordonez","year":"1998","journal-title":"Am J Clin Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817706006897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817706006897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T07:55:32Z","timestamp":1547020532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817706006897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0046817706006897"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2006.11.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}